These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 36822966)
1. Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate model. Sabato B; Augusto PSA; Lima Gonçalves Pereira R; Coutinho Batista Esteves F; Caligiorne SM; Rodrigues Dias Assis B; Apolo Correia Marcelino S; Pires do Espírito Santo L; Dias Dos Reis K; Da Silva Neto L; Goulart G; de Fátima Â; Pierezan F; Toshio Fujiwara R; Castro M; Garcia F Vaccine; 2023 Mar; 41(13):2127-2136. PubMed ID: 36822966 [TBL] [Abstract][Full Text] [Related]
2. Calix[ da Silva Neto L; da Silva Maia AF; Godin AM; de Almeida Augusto PS; Pereira RLG; Caligiorne SM; Alves RB; Fernandes SOA; Cardoso VN; Goulart GAC; Martins FT; das Neves MCL; Garcia FD; de Fátima  J Adv Res; 2022 May; 38():285-298. PubMed ID: 35572397 [TBL] [Abstract][Full Text] [Related]
3. The future potential for cocaine vaccines. Orson FM; Wang R; Brimijoin S; Kinsey BM; Singh RA; Ramakrishnan M; Wang HY; Kosten TR Expert Opin Biol Ther; 2014 Sep; 14(9):1271-83. PubMed ID: 24835496 [TBL] [Abstract][Full Text] [Related]
5. Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies. Schabacker DS; Kirschbaum KS; Segre M Immunology; 2000 May; 100(1):48-56. PubMed ID: 10809958 [TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial. Watanabe A; Nishida S; Burcu T; Shibahara T; Kusakabe T; Kuroda E; Ishii KJ; Kumanogoh A Vaccine; 2022 Jul; 40(31):4150-4159. PubMed ID: 35672178 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials. Ozdarendeli A; Sezer Z; Pavel STI; Inal A; Yetiskin H; Kaplan B; Uygut MA; Bayram A; Mazicioglu M; Unuvar GK; Yuce ZT; Aydin G; Aslan AF; Kaya RK; Koc RC; Ates I; Kara A Vaccine; 2023 Jan; 41(2):380-390. PubMed ID: 36460536 [TBL] [Abstract][Full Text] [Related]
9. Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. Martell BA; Orson FM; Poling J; Mitchell E; Rossen RD; Gardner T; Kosten TR Arch Gen Psychiatry; 2009 Oct; 66(10):1116-23. PubMed ID: 19805702 [TBL] [Abstract][Full Text] [Related]
10. Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines' immunogenicity. Scendoni R; Bury E; Ribeiro ILA; Cameriere R; Cingolani M Hum Vaccin Immunother; 2022 Nov; 18(6):2140552. PubMed ID: 36351881 [TBL] [Abstract][Full Text] [Related]
11. Human therapeutic cocaine vaccine: safety and immunogenicity. Kosten TR; Rosen M; Bond J; Settles M; Roberts JS; Shields J; Jack L; Fox B Vaccine; 2002 Jan; 20(7-8):1196-204. PubMed ID: 11803082 [TBL] [Abstract][Full Text] [Related]
13. Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs. Hicks MJ; De BP; Rosenberg JB; Davidson JT; Moreno AY; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Toth M; Mezey JG; Crystal RG Mol Ther; 2011 Mar; 19(3):612-9. PubMed ID: 21206484 [TBL] [Abstract][Full Text] [Related]
14. Development of a therapeutic vaccine for the treatment of cocaine addiction. Fox BS Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of Abhay M and M-vac vaccines in healthy infants: a phase III multicentric randomized single blind trial. Zodpey SP; Agarkhedkar SR; Reddy GA; Rao MI; Shenoy UV; Murthy SR; Maiya PP Indian J Public Health; 2008; 52(1):5-10. PubMed ID: 18700714 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents. Ben-Yehuda A; Joseph A; Barenholz Y; Zeira E; Even-Chen S; Louria-Hayon I; Babai I; Zakay-Rones Z; Greenbaum E; Galprin I; Glück R; Zurbriggen R; Kedar E Vaccine; 2003 Jul; 21(23):3169-78. PubMed ID: 12804845 [TBL] [Abstract][Full Text] [Related]
20. The GNE-KLH anti-cocaine vaccine protects dams and offspring from cocaine-induced effects during the prenatal and lactating periods. de Almeida Augusto PS; Pereira RLG; Caligiorne SM; Sabato B; Assis BRD; do Espírito Santo LP; Dos Reis KD; Castro Goulart GA; de Fátima Â; de Castro Lourenço das Neves M; Garcia FD Mol Psychiatry; 2021 Dec; 26(12):7784-7791. PubMed ID: 34381172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]